Dupilumab Treatment Leads to Sustained Reductions in Oral Corticosteroid Use in Patients With Oral Corticosteroid-Dependent Severe Asthma

Gurnell, M, Domingo, C, Rabe, K F, Menzies-Gow, A, Price, D, Brusselle, G, Wechsler, M E, Xia, C, Pandit-Abid, N, Gall, R, Jacob-Nara, J A, Rowe, P J, Deniz, Y & Siddiqui, S 2022, 'Dupilumab Treatment Leads to Sustained Reductions in Oral Corticosteroid Use in Patients With Oral Corticosteroid-Dependent Severe Asthma', Chest, vol. 162, no. 4, Supplement, pp. A1909-A1913. https://doi.org/10.1016/j.chest.2022.08.1587